January 31, 2020

A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC

This review article analyzed nine peer-reviewed studies focused on the effects of cannabinoids on Alzheimer’s disease and dementia. Due to the increasing life expectancy in society aging related Alzheimer’s disease onset has continued to increase since 1995. Thus, it is important that we investigate cannabis and its cannabinoids as potential pharmacotherapies for Alzheimer’s disease. The review of studies on CBD indicate that CBD can protect certain neuronal cells from pathological mechanisms present in Alzheimer’s disease. They also showed that CBD can promote neuronal cell growth in the hippocampus of the brain. Additionally, reviewed studies showed that the combination of CBD and THC appear to by more useful than CBD or THC alone in suppressing causal factors of Alzheimer’s disease. There should be continued research into CBD, THC, and other cannabinoids present in cannabis in order to determine their efficacy in preventing and treating Alzheimer’s disease.

View This Research